Belmonte O, Drouet D, Alba J, Moiton M-P, Kuli B, Lugagne-Delpon N, Mourlan C, Jaffar-Bandjee M-C
Laboratoire de Microbiologie et d'Hématologie, Centre Hospitalier Régional de La Réunion, Site Félix-Guyon, Route de Bellepierre, 97405 Saint-Denis, France.
Pathol Biol (Paris). 2010 Feb;58(1):18-24. doi: 10.1016/j.patbio.2009.07.021. Epub 2009 Oct 27.
The antibiotic resistance of enterobacteriacae knows a worldwide worrying evolution with an increase of the extended spectrum betalactamases (ESBL) that spread into the community. Few publications describe this problem in the Indian Ocean area. The aim of this study is first to identify in Félix Guyon Hospital (Reunion Island) the emergent antibiotics resistance for enterobacteriaceae between 1997/1998 and 2006/2007 periods, at second, to update the prophylactic and therapeutic measures for handling the risk linked to multiresistant enterobacteriaceae in our hospital and third, to assess the risk in Reunion Island and especially at the community level.
The antibiotic susceptibility of 7814 enterobacteriaceae strains collected among patients, during 1997/1998 and 2006/2007 periods, were analysed as well as the consumption of the third generation cephalosporins, imipenem and fluoroquinolones.
Within a span of time of 10 years, an important increase (+57 %) of the resistance prevalence of enterobacteriaceae is observed. The resistance by the ESBL production mechanism is predominant especially for Enterobacter cloacae and Escherichia coli. An important use of broad spectrum antibiotics is correlated with this resistance evolution.
The emergence of ESBL-producing enterobacteriaceae in our hospital is impairing both therapeutic and health care. It requires a much better control of antibiotics prescriptions and therefore, an important multidisciplinary implication. A proof molecular analysis would allow to evaluate the risk more precisely, especially at the community level.
肠杆菌科细菌的抗生素耐药性在全球范围内呈现出令人担忧的演变趋势,超广谱β-内酰胺酶(ESBL)的数量不断增加并在社区中传播。在印度洋地区,很少有出版物描述这一问题。本研究的目的,一是在费利克斯·居永医院(留尼汪岛)确定1997/1998年至2006/2007年期间肠杆菌科细菌新出现的抗生素耐药性;二是更新我院针对多重耐药肠杆菌科细菌相关风险的预防和治疗措施;三是评估留尼汪岛尤其是社区层面的风险。
分析了1997/1998年至2006/2007年期间从患者中收集的7814株肠杆菌科细菌的抗生素敏感性,以及第三代头孢菌素、亚胺培南和氟喹诺酮类药物的使用情况。
在10年的时间跨度内,观察到肠杆菌科细菌耐药率显著上升(+57%)。通过ESBL产生机制产生的耐药性占主导地位,尤其是阴沟肠杆菌和大肠杆菌。广谱抗生素的大量使用与这种耐药性演变相关。
我院产ESBL肠杆菌科细菌的出现对治疗和医疗保健均造成了损害。这需要更好地控制抗生素处方,因此需要多学科的重要参与。分子分析证据将有助于更精确地评估风险,尤其是在社区层面。